Gi Oncology Update; Micheal Pishvaian, Md, Phd

GI Oncology Update; Micheal (Mike) Pishvaian, MD, PhD

Updates in Pancreatic Cancer: 2022 - Michael Pishvaian, MD, PhD

Dr. Pishvaian on Precision Medicine in GI Cancer

MedNews Week Keynote Conference - Dr. Michael J. Pishvaian (Johns Hopkins University)

Dr. Pishvaian Discusses the Future of Entrectinib for Pancreatic Cancer

Dr. Pishvaian on Molecular Alteration in Pancreatic Cancer

Dr. Pishvaian on Implications of Entrectinib Study in Pancreatic Cancer

Hope is the Key to Fighting Pancreatic Cancer | Dr. Michael Pishvaian and Carolyn Miles

Genetic Testing Should Be Considered for All Patients With Pancreatic Cancer

Targeted Oncology

Dr. Pishvaian on FDA Approval of Atezolizumab Plus Bevacizumab in HCC

Strategically planning clinical trials to improve outcomes in pancreatic cancer

CancerCast – Updates in Pancreatic Cancer Research and Treatment

Weill Cornell Medicine Hematology & Medical Oncology

Dr. Michael Pishvaian: The Future of Immunology for Pancreatic Cancer Treatment

Passion Struck Clips - John R. Miles

Developing European guidelines for defining and treating oligometastatic esophagogastric cancer

Updates from ASCO GI: 2023 West Oncology

Total Health | Oncology

Clinical Benefit of Entrectinib for Patients With Metastatic Pancreatic Cancer

Targeted Oncology

Advanced GI Cancers: Identifying and Targeting Uncommon but Actionable Genomic Alterations

PeerView Oncology

Perthera: Personalized Cancer Therapy with Dr. Michael Pishvaian

Hope For Stomach Cancer

Advances in GI Cancer Care: The Concept and Reality of Precision Medicine